PubMed

Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists.

Sewter CP, Blows F, Vidal-Puig A, O'Rahilly S.

Diabetes. 2002 Mar;51(3):718-23.PMID: 11872672 [PubMed - indexed for MEDLINE]Related articlesFree article

A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.

Burris TP, Pelton PD, Zhou L, Osborne MC, Cryan E, Demarest KT.

Mol Endocrinol. 1999 Mar;13(3):410-7.PMID: 10076998 [PubMed - indexed for MEDLINE]Related articlesFree article

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S.

J Clin Invest. 1997 Dec 15;100(12):3149-53.PMID: 9399962 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.

Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins JB.

Diabetes. 1998 Jan;47(1):138-41.PMID: 9421389 [PubMed - indexed for MEDLINE]Related articles

Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.

Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL.

Mol Genet Metab. 2001 Nov;74(3):362-9.PMID: 11708867 [PubMed - indexed for MEDLINE]Related articles

Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.

Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ.

Mol Pharmacol. 2001 Apr;59(4):765-73.PMID: 11259621 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.

Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti JR Jr, Henry RR.

Diabetologia. 2001 Apr;44(4):444-52.PMID: 11357475 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.

Armoni M, Kritz N, Harel C, Bar-Yoseph F, Chen H, Quon MJ, Karnieli E.

J Biol Chem. 2003 Aug 15;278(33):30614-23. Epub 2003 May 29.PMID: 12777391 [PubMed - indexed for MEDLINE]Related articlesFree article

Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.

Takamura T, Nohara E, Nagai Y, Kobayashi K.

Eur J Pharmacol. 2001 Jun 22;422(1-3):23-9.PMID: 11430909 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.

Asano T, Wakisaka M, Yoshinari M, Iino K, Sonoki K, Iwase M, Fujishima M.

Biochim Biophys Acta. 2000 Jun 2;1497(1):148-54.PMID: 10838168 [PubMed - indexed for MEDLINE]Related articles

Depot-related gene expression in human subcutaneous and omental adipocytes.

Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S.

Diabetes. 1998 Sep;47(9):1384-91. Erratum in: Diabetes. 2007 Mar;56(3):897. PMID: 9726225 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.

Guan YF, Zhang YH, Breyer RM, Davis L, Breyer MD.

Neoplasia. 1999 Oct;1(4):330-9.PMID: 10935488 [PubMed - indexed for MEDLINE]Related articlesFree article

Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNFalpha.

Niesler CU, Prins JB, O'Rahilly S, Siddle K, Montague CT.

Int J Obes Relat Metab Disord. 2001 Jul;25(7):1027-33.PMID: 11443502 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes.

Sewter C, Blows F, Considine R, Vidal-Puig A, O'Rahilly S.

J Clin Endocrinol Metab. 2002 Sep;87(9):4203-7.PMID: 12213872 [PubMed - indexed for MEDLINE]Related articlesFree article

A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.

Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti JR Jr.

Mol Endocrinol. 2000 Sep;14(9):1425-33.PMID: 10976920 [PubMed - indexed for MEDLINE]Related articlesFree article

PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.

Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J.

EMBO J. 1996 Oct 1;15(19):5336-48.PMID: 8895578 [PubMed - indexed for MEDLINE]Related articlesFree article

The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.

Cesario RM, Klausing K, Razzaghi H, Crombie D, Rungta D, Heyman RA, Lala DS.

Mol Endocrinol. 2001 Aug;15(8):1360-9.PMID: 11463859 [PubMed - indexed for MEDLINE]Related articlesFree article

Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes.

Digby JE, Crowley VE, Sewter CP, Whitehead JP, Prins JB, O'Rahilly S.

Int J Obes Relat Metab Disord. 2000 May;24(5):585-92.PMID: 10849580 [PubMed - indexed for MEDLINE]Related articles

Regulation of aromatase by nuclear receptors.

Yanase T, Mu YM, Nishi Y, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H.

J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):187-92.PMID: 11850224 [PubMed - indexed for MEDLINE]Related articles

Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes.

van Harmelen V, Dicker A, Rydén M, Hauner H, Lönnqvist F, Näslund E, Arner P.

Diabetes. 2002 Jul;51(7):2029-36.PMID: 12086930 [PubMed - indexed for MEDLINE]Related articlesFree article